CPC C07D 401/04 (2013.01) [A61K 31/444 (2013.01); A61P 31/04 (2018.01); A61P 31/10 (2018.01); A61K 31/473 (2013.01)] | 9 Claims |
1. A 10-(2-hydroxyethyl)-9-(2-hydroxypyridin-3-yl)-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione compound having the formula I:
|
2. A pharmaceutically acceptable composition comprising a therapeutically effective amount of the 10-(2-hydroxyethyl)-9-(2-hydroxypyridin-3-yl)-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione compound of claim 1 and a pharmaceutically acceptable carrier.
|